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ARTICLE
Monomeric ephrinB2 binding induces allosteric
changes in Nipah virus G that precede its full
activation
Joyce J.W. Wong1, Tracy A. Young2, Jiayan Zhang3,4,5, Shiheng Liu4,5, George P. Leser6,7, Elizabeth A. Komives8,
Robert A. Lamb6,7, Z. Hong Zhou4,5, Joshua Salafsky2 & Theodore S. Jardetzky1
Nipah virus is an emergent paramyxovirus that causes deadly encephalitis and respiratory
infections in humans. Two glycoproteins coordinate the infection of host cells, an attachment
protein (G), which binds to cell surface receptors, and a fusion (F) protein, which carries out
the process of virus-cell membrane fusion. The G protein binds to ephrin B2/3 receptors,
inducing G conformational changes that trigger F protein refolding. Using an optical approach
based on second harmonic generation, we show that monomeric and dimeric receptors
activate distinct conformational changes in G. The monomeric receptor-induced changes are
not detected by conformation-sensitive monoclonal antibodies or through electron micro-
scopy analysis of G:ephrinB2 complexes. However, hydrogen/deuterium exchange experi-
ments confirm the second harmonic generation observations and reveal allosteric changes in
the G receptor binding and F-activating stalk domains, providing insights into the pathway of
receptor-activated virus entry.
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The Paramyxoviridae are enveloped, negative-strand RNAviruses that infect both humans and animals. The familyincludes many important human pathogens such as
mumps virus, measles virus, respiratory syncytial virus, human
metapneumovirus, parainfluenza viruses, Nipah virus, and Hen-
dra virus1. Nipah and Hendra viruses, which define the Heni-
pavirus genus within the Paramyxoviridae, cause periodic
outbreaks of encephalitic and respiratory illness in humans with
high morbidity and mortality. They are therefore designated BSL-
4 agents and no human vaccines or therapeutics are currently
available for these viruses.
The entry of paramyxoviruses into host cells requires the
merger of the viral lipid envelope and the host cell plasma
membrane1, 2. For the Henipaviruses, this process is triggered by
specific binding of the attachment protein, G, to its host cell
receptors, ephrinB2 or ephrinB33–5. The G protein is a tetramer
with an N-terminal transmembrane domain, an extramembrane
stalk domain, consisting of a membrane proximal alpha-helical
portion and distal proline-rich portion6, and a C-terminal glob-
ular receptor-binding domain (RBD) that has a 6-bladed beta-
propeller fold7, 8. EphrinB2/B3 are members of the B-class of
ephrin ligands, which endogenously function in cell signaling via
interaction with EphR receptors. B-class ephrins are transmem-
brane proteins with a receptor-binding ectodomain that are
thought to form loose dimers9. The current prevailing model for
Henipavirus fusion is that G forms complexes with the fusion (F)
protein prior to fusion triggering10–12. Binding of ephrin B2/3 is
thought to result in a series of rearrangements in the G tetramer
that culminate in the exposure of stalk domain residues that
activate F, but are occluded by the head domains in the untrig-
gered state11, 13, 14. These rearrangements are thought to involve
changes in the quaternary structure of the G tetramer, as very
little change occurs within the henipavirus G RBDs in crystal
structures with ephrinB2 or B315, 16. Contacts between exposed G
stalk residues and F are hypothesized to then cause F to transition
from its pre- to postfusion state, drawing the host and viral
membranes together to promote bilayer fusion.
Evidence for receptor-induced Nipah virus G (NiV G) rear-
rangements comes from changes in NiV G circular dichroism,
Raman spectra, and binding affinity to a panel of conformation-
specific anti-NiV G antibodies13, 14, 17–19. Notably, an epitope
immediately preceding the N-terminus of the NiV G RBD
recognized by monoclonal antibody mAb45 and a stalk domain
epitope recognized by polyclonal antibody Ab167 become more
tightly bound by their respective antibodies, while an epitope on
the globular head domain recognized by monoclonal antibody
mAb213 becomes less bound13, 17. Similarly, a panel of mono-
clonal antibodies specific to Hendra G (HeV G) shows increases
in binding to HeV G upon ephrinB2 addition20. Site-directed
mutants throughout the NiV G ectodomain exhibit different
profiles for binding to these conformational antibodies. These
data, combined with the mutant profiles for fusion activity,
receptor binding, and F binding, has led to a model in which a
multi-step cascade of G conformational changes occurs during
fusion activation, which may be arrested at various stages by the
G mutants13, 14. However, little is known about the details of
these conformational changes and how ephrin B2/3 binding to
the G RBDs leads to their induction.
Receptor-induced conformational changes in the attachment
proteins of other members of the paramyxovirus family are also
thought to be part of their fusion mechanisms. The crystal
structures of the PIV5 and NDV HN ectodomains and the
measles virus H receptor binding domains (RBDs) exhibit varying
orientations with respect to each other21–23. In addition,
restraining the H protein stalk helices of measles virus H and
canine distemper virus H with inter-chain disulfide bonds dis-
rupts fusion24, 25. The F-activating role of the exposed attachment
protein stalk is supported by constitutive activation of para-
myxovirus fusion with headless attachment protein
constructs13, 26–28, fusion activation by chimeric attachment
proteins with heterotypic head domains and homotypic stalks29
and the disruption of fusion by stalk domain mutants that
modulate interactions with F30–32.
To understand better the conformational changes induced in
NiV G upon binding its host receptor ephrinB2, we explored the
possibility of using second harmonic generation (SHG) to
monitor G conformational states. Since the concept of using SHG
to study proteins at an interface was introduced33, it has been
used to detect a variety of ligand-induced conformational changes
in proteins that are tethered to a planar surface34–37. Proteins are
labeled with SHG-active dye molecules, which are covalently
attached to protein side chains and provide a reporter signal that
is sensitive to the dye orientation and conformational changes33.
The SHG signal is very sensitive to small changes in SHG label
orientation, being proportional to <cos3θ>2, where θ is the angle
between the SHG label’s molecular dipole and the surface normal
and the brackets denote an orientational average over all mole-
cules under illumination by the laser beam. The SHG signal is
thus sensitive to both the mean angle and the width of the dye
conformational distribution and is therefore potentially capable
of detecting changes in protein dynamics in the absence of net
conformational changes34. Subtle changes in this distribution due
to changes in conformation result in changes in SHG intensity
with a good signal to noise ratio. Therefore, distinguishing NiV G
states in terms of both net conformation and dynamic flexibility is
potentially possible using this technique. Previous reports have
shown that non-specific lysine labeling at multiple sites still
allows ligand-induced changes to be detected readily34, 35, 38.
Here we study the ephrinB2-induced conformational changes
in NiV G using SHG, hydrogen-deuterium exchange mass spec-
trometry (HDX-MS), antibody binding, and electron microscopy
(EM). SHG studies indicate that monomeric ephrinB2 (com-
prising only the globular portion of its ectodomain) induces
conformational changes in G that are distinct from dimeric
ephrinB2 (a chimera with an Fc domain that mediate dimeriza-
tion). Surprisingly, monomeric ephrinB2 does not significantly
alter the binding of two anti-G conformational antibodies as
compared to ephrinB2-Fc. Consistent with the mAb binding
results, EM analysis of NiV G complexed with monomeric
ephrinB2 also revealed no large-scale conformational changes.
Because the SHG data indicated that G undergoes conformational
changes upon monomeric ephrinB2 binding that are not detected
by conformation-sensitive antibodies, we used HDX-MS to study
the impact of receptor binding on G. HDX-MS analysis of G
reveals significant differences in H/D exchange for peptides in the
globular RBD and in the N-terminal stalk domain upon binding
to monomeric ephrinB2, indicating that allosteric changes are
induced, consistent with the SHG observations. Together, these
data support a model in which monomeric receptor binding
induces allosteric changes in individual G subunits, conveyed
through the RBD to the helical stalk domains, which prime the
tetramer to undergo further conformational changes induced by
oligomeric receptors to promote F-mediated membrane fusion.
We conclude that SHG provides a powerful and sensitive
approach to detecting subtle conformational and dynamic
changes in protein structures that complements other structural
and biophysical techniques. In addition, our EM analysis of the
NiV G tetramer reveals a different arrangement of RBDs as
compared to crystal structures of the ectodomains of HN proteins
from Newcastle disease virus and parainfluenza virus 5.
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Results
SHG signal change in NiV G in response to ephrinB2 binding.
Wildtype NiV G ectodomain was labeled through free amino
groups with SHG-active dye in order to provide a reporter for
potential conformational changes. The percentage of total label-
ing at each detected lysine residue showed modification of a
dominant site in the NiV G head domain, K201 (Fig. 1a and
Supplementary Table 1). Production of an SHG signal depends
on the non-isotropic orientation of the SHG-active label with
respect to a surface or interface (Fig. 1b), as well as the width of
the orientational distribution (Fig. 1c). We used the Biodesy Delta
instrument for measuring SHG, where NiV G ectodomains were
captured through N-terminal His6 tags by Ni-NTA groups in a
supported lipid bilayer (Fig. 1d).
The specificity of the NiV G SHG response to ephrinB2 was
tested in a dose-response titration of ephrinB2-Fc, competition
experiments, and with a non-NiV G reactive ephrin isotype,
ephrinA1. Wildtype NiV G showed a greater negative SHG
response (ΔSHG) to increasing concentrations of ephrinB2-Fc
(Fig. 1e and Supplementary Fig. 1). Pre-incubation of ephrinB2-
Fc with known competitors of NiV G for ephrinB2 binding
(unlabeled wildtype NiV G or the ephrinB2 receptor, EphB2)
greatly reduced the observed ΔSHG, consistent with their
competition for ephrinB2 binding to NiV G (Fig. 1f).
NiV G mutants exhibit distinct SHG signal changes. Four
site-directed mutants of NiV G with differing conformational
antibody binding profiles were chosen for analysis by SHG rela-
tive to wildtype: K376A, C387A, Q388A, and L181A (Fig. 1a).
K376A, C387A, and Q388A are part of region 9 (residues
371–392), which shows decreased binding to mAb213 upon
ephrinB2 binding to NiV G13. L181A is near region 4N
(195–211), which shows increased binding to mAb45 in the
presence of ephrinB2. Region 9 is believed to undergo an
ephrinB2-triggered conformational change before region 4N.
Prior studies of antibody binding to the G mutants in the absence
of receptor indicated wildtype behavior for K376A, lower overall
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Fig. 1 Detection of ephrinB2 binding to NiV G by SHG. a Crystal structure of the globular domain of NiV G bound to the globular domain of ephrinB2. NiV G
conformational mutants are indicated in purple, and the dominant labeling site of NiV G is indicated in yellow. Epitopes for conformation-sensitive
antibodies mAb45 and mAb213 are indicated in gray. b Prior to ligand binding, the SHG label representing protein conformational ensemble S1 has an
average orientation angle θ1 relative to the surface normal. Ligand binding elicits protein conformation ensemble S2 with an average label orientation θ2. c
The SHG signal depends on both the average label orientation θ and the width of the orientational distribution σ of the probe. Rearrangements in protein
structure upon ligand binding that result in changes of either θ, σ, or both will be reflected in the SHG signal change. d Biodesy read plate setup. A NiV G
ectodomain construct with an N-terminal His6-tag was oriented in a fixed manner via binding of the His6-tag to Ni-NTA groups on a supported lipid
bilayer. The globular domains are represented by pink rectangles, and the stalk domain by dashed pink lines. e Δ SHG concentration-dependent dose-
response of ephrinB2-Fc binding to NiV G. His6-tagged NiV G ectodomain construct was bound to Ni-NTA-containing supported lipid bilayer at 0.5 μM.
EphrinB2-Fc was added to the indicated final concentrations. f Negative controls for SHG response in NiV G ectodomain constructs. NiV G was bound at
0.5 μM and ephrinB2 constructs and competitors were added at indicated amounts (μM). Mean and s.d. values for SHG data are shown from a
representative experiment, n= 3
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binding for C387A to all antibodies, a large decrease in binding to
mAb213 for Q388A, and an increase in binding to mAb45 for
L181A. In the presence of ephrinB2, C387A showed relatively
little change in mAb213 and mAb45 binding compared to wild-
type. L181A showed a similar decrease in mAb213 binding to
wildtype and an unchanged level of mAb45 binding13. Overall,
these data suggested that the conformations and receptor-induced
changes in the mutants were distinct. We were therefore inter-
ested in examining these mutants using SHG to determine
whether they exhibited distinct conformational signatures indi-
cative of altered conformations.
The mutant G proteins were purified and labeled similarly to
the wildtype protein, with degrees of labeling of 1.67± 0.15.
Liquid chromatography tandem mass spectrometry (LC-MS)
analysis of the labeled proteins indicated that the wildtype and
mutant proteins were labeled mostly similarly across all
constructs, though substantial differences exist for several
residues, notably K130, K386, and K415 (Supplementary Table 1).
None of the mutants responded to the control ephrinA1-Fc
(Fig. 1f), but three of them (K376A, Q388A, and L181A) showed
comparable, but distinct, SHG signal changes in the presence of
ephrinB2-Fc (Fig. 2a). The C387A mutant did not show a
significant SHG response in the presence of 0.6 μM ephrinB2-Fc,
but at 10 μM ephrinB2-Fc, the C387A mutant yielded ΔSHG
comparable to wildtype G (−21.9%; Supplementary Fig. 1).
K376A and Q388A showed similar ΔSHG values to each other
(−32.9 and −31.9%, respectively), which were greater than those
from the wildtype G (Fig. 2a, Supplementary Fig. 2). L181A
showed a ΔSHG between wildtype and the K376A or Q388A
mutants, (−27.1%). The variable ΔSHG values observed could be
consistent with the mutants initiating from different
conformational states, as previously proposed, but we cannot
exclude the possibility that some variability in dye labeling may
contribute as well. Nonetheless, these data indicate that all of the
G mutants are capable of undergoing ephrinB2-Fc induced
conformational changes.
EphrinB2 binding affinity of NiV G mutants. The observed
SHG responses for the wildtype and G mutants could potentially
arise from differences in binding affinity of ephrinB2 for the
mutants, in particular for C387A38. We measured direct binding
of ephrinB2 to the wildtype and mutant proteins using an
oriented enzyme-linked immunosorbent assay (ELISA) assay. All
of the mutants, except for C387A, show similar ephrinB2-Fc
binding affinities to wildtype, which has a Kd of 0.088 nM
(Fig. 2b). In contrast, binding data for the C387A mutant did not
reach saturation at μM concentrations of ephrinB2-Fc, yielded
inconsistent replicates, and could not be fit to standard binding
curve models. Therefore, we used a competitive binding assay to
measure C387A binding affinity relative to wildtype. C387A
competed with wildtype NiV G with weaker Ki (Fig. 2c). We
therefore conclude that the lack of SHG signal response in C387A
at low ephrinB2-Fc concentrations is most likely due to weaker
ephrinB2 binding affinity (consistent with NiVG-ephrinB2
binding levels reported in ref. 13) rather than differing con-
formational response. For all of the other tested mutants, the
similarity in binding affinity indicates that the observed differ-
ences in SHG response are due to other causes.
EphrinB2-induced changes in mAb213 and mAb45 binding to
NiV G. Previous studies have examined conformational changes
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Fig. 2 Response of NiV G mutants to ephrinB2-Fc binding measured by SHG and conformational antibody binding. a Change in SHG signal of NiVG
ectodomain constructs bound at 0.5 μM at 20min following ephrinB2-Fc addition to 0.6 μM. b Binding affinity of ephrinB2-Fc to NiV G ectodomain
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in the full length, membrane embedded NiV G protein, using the
conformation-sensitive antibodies mAb213 and mAb4513. To
determine whether the soluble, NiV G ectodomain exhibits
similar changes, all of the NiV G ectodomain constructs were
tested for binding to mAb213 and mAb45 in the presence of
increasing amounts of ephrinB2-Fc. Wildtype and two mutants
(K376A and L181A) showed decreases in mAb213 binding as
ephrinB2 is titrated (Fig. 2d), consistent with the previously
reported studies of full-length G13. The Q388A mutant showed
no binding to mAb213, which is consistent with the mutation
destroying the antibody epitope as previously reported (Fig. 2d).
mAb45 binding increases after ephrinB2-Fc binding to
full-length NiV G and we observe a similar increase with the
NiV G ectodomain proteins (Fig. 2e). However, it is notable that
L181A has significantly higher mAb45 initial binding prior to
ephrinB2-Fc addition and saturates at a lower level compared to
wildtype. This is consistent with previous observations made with
full-length G. These differences were interpreted to mean that
L181A is prematurely triggered, at least partially revealing the
mAb45 epitope early so that the span of signal change between
the receptor bound and unbound states is smaller compared to
wildtype13. C387A binding to mAb45 is minimal at 1.2 μM
ephrinB2 (Fig. 2f), consistent with its weak binding to ephrinB2-
Fc and lack of SHG response. Overall these data demonstrate that
ephrinB2-Fc binding to secreted wildtype and mutant G
ectodomains recapitulates the antibody-sensitive conformational
changes observed with the full-length G.
Negative stain EM analysis of wildtype and mutant NiV G.
Given the differences in ΔSHG, antibody binding and receptor
binding that we observed for the mutants and wildtype NiV G, we
investigated whether any structural differences could be observed
by negative stain EM. Micrographs of the wildtype and mutant
NiV G reveal that all of the proteins form well-defined tetramers
with globular domains positioned around a central stalk (Sup-
plementary Fig. 3). Individual particles of the tetramers suggested
that the G RBDs are more separated from each other compared to
the dimer-of-dimers observed in the crystal structures of its
paramyxovirus homologs, PIV5 and NDV HN22, 23. Comparisons
of the wildtype and mutant NiV G particles do not indicate any
large-scale conformational differences that could account for the
observed differences in antibody binding, ΔSHG or ephrinB2
binding. Notably, this includes the L181A mutant, for which
mAb45 binding differences were interpreted as evidence for its
adoption of a pre-triggered conformation prior to receptor
binding13 and for which similar effects were observed with our
secreted ectodomain construct. The EM data indicate that the
potential conformational differences detected by antibody bind-
ing may be relatively small. To visualize the effects of ephrinB2-Fc
binding to G, complexes of NiV G with ephrinB2-Fc were pre-
pared and isolated using size exclusion chromatography (Sup-
plementary Fig. 6a) for EM studies. However, the EM samples
appeared non-homogenous and aggregated (Supplementary
Fig. 6b), most likely due to the ability of the dimeric ephrinB2-Fc
construct to cross-link multiple NiV G tetramers.
EphrinB2 oligomeric states induce distinct changes in NiV G.
We next asked if monomeric ephrinB2 binding to NiV G induces
similar SHG and conformation-sensitive antibody binding
responses. We generated two monomeric ephrinB2 constructs.
EphrinB2-167 consists of only the NiVG-binding globular
domain observed in crystal structures8, residues 25–167 (Fig. 3a).
The second construct, ephrinB2-229, contains the entire
ephrinB2 ectodomain (residues 25–229), which are also included
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in the ephrinB2-Fc fusion constructs (Fig. 3a). Strikingly, the
shorter, monomeric ephrinB2-167 yielded the largest ΔSHG
(−27.9%), while the longer monomeric construct (ephrinB2-229)
was more similar to the dimeric receptor with ΔSHG values of
−15.9 and −12.9%, respectively (Fig. 3b and Supplementary
Fig. 4). The binding affinities of ephrinB2-167 and ephrinB2-229
are 11.9 nM and 33.2 nM, respectively, within the same order of
magnitude of the Kd previously reported8 (Supplementary Fig. 5),
and weaker than the binding of the bivalent ephrinB2-Fc. The
SHG data indicate that the monomeric ephrins induce con-
formational changes in G, although the magnitude of the con-
formational changes cannot be easily inferred from the
magnitude of the ΔSHG observed. Relatively small changes in the
reporter dye orientation or the distribution of protein dynamic
states could yield significant ΔSHG changes, with sensitivity to 1
Å changes in structure as previously reported37.
To determine whether the monomeric ephrinB2 proteins also
induce conformational changes detected by the mAb45 and
mAb213 antibodies, we conducted binding studies of the
antibodies in the presence of increasing concentrations of the
three receptor constructs. mAb213 binding to NiVG is unaffected
by the monomeric ephrinB2 constructs even at >10× the Kd,
while parallel experiments with the ephrinB2-Fc exhibited the
expected decrease in mAb213 binding at <10× its Kd (Fig. 3c).
Similarly, ephrinB2-Fc induces a large increase in mAb45
binding, while the monomeric ephrinB2 proteins show little to
no effects (Fig. 3d). The ephrinB2-167 construct shows slightly
increased mAb45 binding compared to the longer ephrinB2-229
construct, but this is insignificant as compared to the effect of the
dimeric ephrinB2-Fc. The mAb binding data suggest that
monomeric ephrin cannot induce the full conformational
transitions in G. However, the ΔSHG from the monomeric
receptor binding indicated that conformational or dynamic
changes in G are still induced, which could precede larger
changes triggered by ephrinB2-Fc binding.
Negative stain EM of apo- and ephrinB2 monomer-bound NiV G.
To directly examine potential conformational changes caused by
monomeric receptor binding, NiVG complexes with ephrinB2-
167 were examined by negative stain EM. The complexes were
prepared by incubation with excess ephrinB2 followed by pur-
ification on a size exclusion column (Supplementary Fig. 6a).
These complexes were then visualized by negative stain EM for
comparison with the apo-form.
2D class averaging of unbound NiV G particles revealed that it
forms an asymmetric tetramer, with a dimer of globular domains
at its apical end and 2 monomeric globular domains on either
side of its central stalk, with no dominant classes. There is some
variability in the rotation of the upper and lower pair of dimers
with respect to each other, and in the distance between the lower
pair of head domains, indicating some degree of conformational
flexibility in the tetramer (Fig. 4a, c).
2D class averaging of ephrinB2-167:G complexes showed a
similar distribution of tetramer conformations with no obvious
change from unbound NiV G (Fig. 4b, c). The bound ephrinB2-
167 monomer is visible as additional density at the membrane-
proximal side of the lower pair of globular domains, but no
additional density can be seen at the upper 2 domains (Fig. 4c).
These results further indicate that binding of monomeric
ephrinB2 to NiV G is insufficient to cause large-scale conforma-
tional changes in the tetramer.
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Fig. 4 Ectodomain of NiV G visualized by negative stain electron
microscopy in the presence and absence of monomeric ephrinB2. a 2D
class averages of apo-NiV G. Class distribution proportion is indicated for
each class. b 2D class averages of NiV G bound to ephrinB2-167. Class
distribution proportion is indicated for each class. c Representative 2D class
averages of apo- and ephrinB2-167-bound NiV G, indicating flexibility
between the lower and apical pairs of NiV G globular domains
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HDX-MS of apo- and ephrinB2-167-bound NiV G. To further
test the possibility that monomeric ephrin binding induces
changes in NiV G and to gain insight into specific regions of G
that undergo changes upon ephrinB2 binding, we conducted
HDX-MS experiments in the presence and absence of ephrinB2-
167. The shorter ephrinB2 construct was used to minimize
potential peptide overlaps with G. The H/D exchange differences
between ephrinB2-bound and unbound G in peptide regions
throughout G are shown in a composite heat map of peptide
exchange rates in Fig. 5a. Time-dependent data on individual
peptides showing notable differences in exchange rate are shown
in Fig. 5b.
The peptide exchange data reveal a wide variety of exchange
differences in both the head and stalk domains due to monomeric
ephrinB2 binding. Some peptides are unaffected by the presence
of receptor (white). Other peptides show reduced exchange when
receptor is bound (blue), indicating potential stabilization of the
G structure, while other peptides show significant increased
exchange in the presence of receptor (red). Strikingly, the
predicted alpha-helical region of the stalk contains two peptides
that define one of the predominant regions with increased H/D
exchange (Fig. 5a). These peptides span residues 81–111 and
127–140. These residues are not involved in ephrinB2 binding,
indicating that receptor binding induces an allosteric change in
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Fig. 5 Hydrogen-deuterium exchange mass spectrometry of the NiV G ectodomain in the presence and absence of monomeric ephrinB2. a Relative
fractional exchange rates of NiV G residues. Residue ranges were defined by the heatmap generated with DynamX. b Hydrogen-deuterium exchange rates
for selected NiV G peptides from apo- and ephrinB2-167-bound NiV G. Mean and s.d. values for deuterium uptake are shown for each time point, n= 3. c
Relative fractional exchange rates of key NiV G regions mapped onto the crystal structure of the NiV G globular domain bound to monomeric ephrinB2.
Residue ranges were defined as in a. d Estimated location of the predicted α-helical stalk region of NiV G (black line) superposed on a representative 2D
class average of NiV G obtained by electron microscopy. The estimated location of peptide 127–140, which undergoes the greatest increase in exchange
upon ephrinB2-167 binding is shown with a red line
NATURE COMMUNICATIONS | DOI: 10.1038/s41467-017-00863-3 ARTICLE
NATURE COMMUNICATIONS |8:  781 |DOI: 10.1038/s41467-017-00863-3 |www.nature.com/naturecommunications 7
the G RBD that is propagated to the stalk. Peptides spanning
residues 255–266 and 321–337, which lie within the RBD, also
show increased H/D exchange in the presence of receptor
(Fig. 5a–c). These residues form a contiguous region on the
ephrinB2-distal face of the beta-propeller domain, which could be
involved in transmitting the allosteric change to the G stalk
domain. Finally, RBD loops that are in close proximity to the
ephrinB2-binding interface show the most overall decrease in
exchange (Fig. 5c), consistent with the direct stabilization of these
regions by ephrinB2 binding. Peptides from the receptor binding
loops with some of the largest decreases in H/D exchange
correspond to residues 454–463, 497–503, and 526–537 (Fig. 5b,
c). The largely beta-strand region of residues 588–593 shows the
next largest decrease in solvent exchange with ephrinB2 binding.
The peptide that undergoes by far the largest increase in solvent
exchange, 127–140, maps to a potentially solvent-exposed region
between pairs of RBDs in both the apo- and ephrinB2-bound
forms (Fig. 5d). The H/D exchange data indicate that monomeric
ephrinB2 binding induces both local and distributed changes in
the G structure, consistent with the SHG observations.
Discussion
The prevailing model for the activation of Henipavirus entry is
that sequential conformational changes in G occur in response to
ephrinB2 binding, forming a pathway to F protein activation.
Previous observations support a model in which these changes in
the G protein conformation culminate with the head domains of
G moving to free its stalk domain to interact with F in a manner
that activates its refolding13, 14. The structural nature of the
conformational changes and the residues of G involved in leading
to this activated state have been unclear. To address these gaps,
we have employed multiple techniques to probe for conforma-
tional changes in NiV G in response to ephrinB2 binding: SHG,
antibody reactivity profiling, HDX-MS, and EM.
We observe that induced conformational changes in the NiV G
ectodomain are dependent on the ephrin oligomerization state.
Both monomeric and dimeric ephrinB2 trigger G conformational
changes measured by SHG, with the monomeric receptor yielding
an overall larger signal. However, monomeric ephrinB2 binding
to G fails to induce conformational changes detected by two
conformation-sensitive mAbs (mAb45 and mAb213). In contrast,
dimeric ephrinB2-Fc induces changes in mAb45 and mAb213
binding to secreted G ectodomain similar to those in previously
studied full-length NiV G. We also observed differences in ΔSHG
and mAb binding with G mutants that have been suggested to
affect the initial G conformational state. However, negative stain
EM studies of the wildtype and mutant G proteins suggest that
these potential conformational differences may be small relative
to the overall G architecture. Negative stain EM of monomeric
receptor-bound G also failed to identify any significant changes in
the G structure relative to uncomplexed G, consistent with the
absence of conformational changes monitored by mAb binding.
Although monomeric receptor binding does not induce sig-
nificant changes in mAb binding, the large ΔSHG indicated that
G still undergoes a significant change in conformation or
dynamics.
To further probe the effects of monomeric ephrinB2 on NiV G,
we used HDX-MS to examine changes in the H/D exchange
profiles of G-derived peptides. Monomeric ephrinB2 binding
induced increases and decreases in H/D exchange in peptides
distributed throughout the G sequence and structure, pointing to
allosteric effects on peptides distant from the receptor binding
site. The largest increase in exchange was in a stalk region con-
taining residues 128–140, and the largest decrease in exchange
was an ephrinB2-protected loop within its binding pocket,
455–462. Two other regions that exhibit increases in exchange
map to adjacent loop regions (residues 253–266 and 321–337) on
the same the side of the G RBD (Fig. 5c) and these are distant
from the receptor binding site, indicating that receptor binding
induces allosteric changes within the beta-propeller domain.
The SHG, mAb binding, EM, and HDX-MS data support a
model in which ephrin-B2 monomer binding to G induces
allosteric changes that propagate from the receptor-binding site
to the stalk domain, without inducing the full conformational
change caused by oligomeric receptor. The increased exchange of
RBD residues 253–266 and 321–337 may identify a region of the
RBD that interacts directly with the stalk domain, thereby
influencing the stability and H/D exchange of stalk peptides
81–111 and 127–140. Monomeric receptor binding appears to
induce changes in individual G subunits that would prime further
conformational changes induced by oligomeric receptor, poten-
tially reducing the strength of RBD:stalk interactions to allow
subsequent conformational rearrangements.
Since the net conformation of the NiV G tetramer remains
similar following ephrinB2 binding, SHG and HDX-MS are likely
monitoring changes in G conformation dynamics or more subtle
conformational changes at specific residues rather than large-
scale conformational changes that would move the RBDs away
from the stalk domain. Notably, movement of the lower two
globular domains into a “heads-up” conformation, previously
proposed as a mechanism for paramyxovirus activation, was not
observed. We note that crystal structures of receptor-bound G do
not reveal significant conformational changes in the G RBD8, 15,
indicating that the allosteric effects on peptide exchange may
depend on the presence of the stalk domain and/or be due to
dynamic differences in these structural regions rather than net
conformational changes. The discovery of multiple protein-ligand
interactions that cause allosteric effects at distal sites in the pro-
tein without apparent conformational change supports the line of
thought that allostery can be propagated solely via changes in the
thermal fluctuations of the protein39, 40. It may be that this is the
case for NiV G, at least during the initial stage of activation when
only an ephrinB2 monomer binds. Whether large-scale con-
formational changes are induced by dimeric ephrinB2-Fc binding
in G was not possible to address in this study given the difficulty
in imaging aggregated complexes (Supplementary Fig. 6b).
Negative stain EM revealed that NiV G is an asymmetric tet-
ramer with an apparent dimer of globular domains at the far end
of the stalk and a separated pair of globular domains in the
middle of the stalk, which differs significantly from dimer-of-
dimer structures observed in the related PIV5 and NDV HN
proteins22, 23. While the observed HDX-MS data suggest a
potential route for the propagation of dynamic changes from the
receptor binding site to the stalk, through a lateral face of the
RBD, the asymmetric structure of the G tetramer complicates this
interpretation. Exchange rates from some of the NiV G peptides
may represent a mixture of at least 2 different populations based
on distinct interactions within the G tetramer. Nonetheless, the
propagation of allosteric changes within both the RBD and stalk
domains provides a compelling explanation for G activation and
enables further studies of the functional roles of the G residues
involved.
Molecular dynamics simulations of binding of an ephrinB2
monomer to NiV G identified residues that could make up a
potential signaling pathway within the RBD and also resulted in
little overall change in NiV G conformation41, 42. These com-
putational studies identified residues 203–211 as undergoing the
most significant net conformational changes upon ephrinB2
binding. This region is part of a peptide that undergoes a mild
decrease in H/D exchange upon ephrinB2 binding (Fig. 5a, b and
Supplementary Fig. 8a). Molecular dynamics simulations of
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ephrinB2 binding to the crystallographic NiV G dimer resulted in
significant reorientation of the dimer43. It is interesting to note
the correlation in solvent accessibility of key peptides in these
simulations with the H/D exchange rates in our study. NiV G
residues unique to the ephrinB2-unbound crystallographic NiV G
dimer interface are largely located in the two adjacent RBD
peptides which show an increase in H/D exchange
(Supplementary Fig. 8b), while residues unique to the ephrinB2-
bound dimer interface following MD simulation include peptides
that undergo decrease in H/D exchange upon receptor binding
(Supplementary Fig. 8c).
The structure of the fully-activated NiV G-ephrinB2 signaling
complex is still unknown, but what is known about
ephrinB2 signaling via its native Eph receptors is highly sugges-
tive of higher level oligomerization of ephrinB2. EphrinB2 is
thought to form loosely associated dimers prior to stimulus, and
during a signaling event forms 2:2 clusters with EphR, followed
by higher order multimerization9, 44. While ephrinB2-expressing
pseudovirions were able to cause NiV G and F displayed on
pseudovirions or mammalian cells to undergo conformational
changes and F to transition to its postfusion form, addition of
soluble ephrinB2-Fc protein to was unable to trigger F, and
induced less G conformational change18. Currently there is no
direct observation of ephrinB2 clustering in response to NiV G
binding or vice versa. However, clustering of HN and F from
human parainfluenza virus 3 in response to cell surface sialic acid
receptors has been observed in live cells45, suggesting an analo-
gous mechanism may occur in henipaviruses. These findings in
total allow us to speculate on a sequence of NiV G-activating
events from initial ephrinB2 monomer contact, binding of both
heads of ephrinB2 dimers to NiV G globular domains, and finally
events that can only occur with ephrinB2 clustering and/or pre-
sence of a target cell membrane.
Methods
Cloning of NiV G and ephrinB2 constructs. A NiV G ectodomain construct
consisting of the gp64 signal peptide, His6-tag, enterokinase cleavage site, and NiV
G residues 71–602 was synthesized (Supplementary Table 2) and cloned into the
SalI and NotI restriction sites of pENTR1A, and transferred to expression vec-
tor pcdnaDEST40 by Gateway cloning with LRII Clonase (Life Technologies).
Site-directed mutants of the NiV G ectodomain were created by Gibson assembly
with the mutant codon in the overlapping ends of the PCR-generated Gibson
assembly fragments. An ephrinB2-Fc construct (ephrinB2-Fc) consisting of resi-
dues 1–229 of human ephrinB2-Fc, a Factor XA cleavage site, and residues
100–330 of human IgG1 was synthesized and cloned into the EcoRI and NheI sites
of pTT5 (National Research Council of Canada). An ephrinB2 monomer construct,
His6-ephrinB2-167, consisting of the gp64 signal peptide, His6-tag, enterokinase
cleavage site, and ephrinB2 residues 25–167 was synthesized and cloned into the
EcoRI and NotI sites of pTT5 (National Research Council of Canada). The His6-
tag was replaced with a S-tag using a Q5 site-directed mutagenesis kit (NEB) to
generate the Stag-ephrinB2-167 construct. The entire plasmid was amplified by
PCR with the S-tag encoding bases split between two back-to-back primers, fol-
lowed by blunt-end ligation. An ephrinB2 monomer construct (ephrinB2-229)
consisting of the gp64 signal peptide, S-tag, enterokinase cleavage site, and
ephrinB2 residues 25–229 was created by PCR overlap extension. A PCR fragment
containing ephrinB2-167 amplified from the Stag-ephrinB2-167-pTT5 plasmid and
a PCR fragment containing an overlap with the 3′ end of fragment ephrinB2-167
followed by ephrinB2 residues168–229 amplified from ephrinB2-Fc-pTT5 plasmid
was combined in a PCR reaction to generate a single fragment. The fragment was
digested with EcoRI and NotI and cloned into the same restriction sites in pTT5.
Expression and purification of NiV G ephrinB2 constructs. HEK 293F cells
grown in Freestyle media (Life Technologies) were transiently transfected with NiV
G pcdnaDEST40 plasmid at high cell density according to a protocol described in
ref. 46. Cell culture medium was harvested 5 days after transfection and dialyzed
with 25 mM sodium phosphate pH 7.6, 200 mM NaCl, 10 mM imidazole. NiV G
was purified from the medium by Ni-NTA chromatography and eluted with a
stepwise imidazole gradient. The peak fractions were further purified by size
exclusion on a Superdex S200 column with 25 mM Tris pH 8.0, 200 mM NaCl, 100
mM imidazole running buffer.
HEK 293 6E cells (National Research Council of Canada) grown in Freestyle
media containing 0.1% Kollifor-188 (Sigma) and 25 μg mL−1 G418 (Invivogen)
were transiently transfected with the ephrinB2-pTT5 plasmid according to the
manufacturer’s instructions (National Research Council of Canada). Cell culture
medium was harvested 5 days after transfection and dialyzed with 25 mM Tris, pH
7.5, 200 mM NaCl. For ephrinB2-Fc, the dialyzed medium was loaded onto Pierce
Protein A Plus beads (Thermo Scientific) and eluted with 3.5 M magnesium sulfate,
25 mM MES pH 6.6, followed by addition of 1M Tris pH 8.0 to a final
concentration of 100 mM. For ephrinB2-167 and ephrinB2-299, the dialyzed
medium was loaded onto Protein S beads (EMD Millipore) and eluted with 3.0 M
magnesium sulfate, 100 mM Tris pH 7.5. The eluates were concentrated and buffer
exchanged into Tris-buffered saline (TBS, 50 mM Tris pH 7.5, 150 mM sodium
chloride), and further purified by size exclusion chromatography on a 10/300 GL
S200 column (GE Healthcare Life Sciences) with TBS running buffer.
Labeling of NiV G with SHG-active dye. NiV G was lysine-labeled with
SHG-active dye (Biodesy, Inc.) via succinimidyl ester chemistry. NiV G was buffer
exchanged into 100 mM sodium bicarbonate, pH 7.5, 150 mM sodium chloride
prior to labeling. The ratio of dye to protein was 2X, resulting in a similar degree of
labeling between wildtype and the mutant proteins of ~ 1.7 dyes/monomer.
Unbound dye was removed and NiV G was exchanged into TBS using 0.5 mL
ZebaSpin 7 K MWCO desalting columns (Thermo Scientific). The sites and degree
of labeling of NiV G residues were determined by Martin-Protean (Princeton, New
Jersey, USA) using LC-MS of denatured, reduced, and deglycosylated NiV G
digested with trypsin and chymotrypsin.
SHG measurements. Supported lipid bilayers were formed by fusion of Ni-NTA
lipid-containing small unilamellar vesicles in TBS to the well surface of 384-well
Biodesy read plates. SHG-labeled-NiV G was bound to the lipid bilayer in 20 μL of
TBS at a concentration of 0.5 μM overnight at 4 °C, followed by washing with TBS.
SHG measurements were made on a Biodesy Delta instrument. p-polarized laser
light is directed through a prism array to create an evanescent wave by total
internal reflection at the well bottom surface. SHG-labeled-NiV G was illuminated
by the evanescent wave, and the resulting signal from the label was detected by a
photomultiplier tube. EphrinB2 protein (ephrinB2-Fc, His6-ephrinB2-167 with the
His6-tag removed by enterokinase cleavage and Ni-NTA cleanup, or ephrinB2-229
(10881-HCCH, SinoBiological Inc.) was added from a reagent plate and mixed by
the instrument’s automated liquid handler. The change in SHG was monitored
over regular time intervals. ΔSHG in % change was calculated using (Ifinal−Iinitial)/
Iinitial × 100.
ELISA measurements of ephrinB2 binding to NiV G. NiV G ectodomain con-
structs were bound via their N-terminal His6-tags to Ni-NTA functionalized
ELISA plates at 0.3 μg mL−1 (Thermo Scientific) and titrated with ephrinB2 con-
structs. EphrinB2-Fc binding was detected by 1:3000 dilution anti-human
IgG-HRP antibody conjugate (GtxHu-004-EHRPX, ImmunoReagents Inc.), and
S-tag ephrinB2-167 and ephrinB2-229 were detected by 1:4000 diluted anti-S tag
antibody (#12774, Cell Signalling Technologies) followed by 1:10,000 diluted anti-
rabbit IgG-HRP antibody conjugate (AP187P, EMD Millipore). All ELISA incu-
bations were performed in 100 μL volumes in buffer consisting of 1% BSA, 1X PBS
(Corning Cellgro) and 0.01% Tween-20 for 1 h, followed by 3 × 250 μL washes of
1X PBS, 0.01% Tween-20. Color development at 630 nM was monitored using a
Synergy 4 platereader (Biotek) following addition of HRP substrate (KPL). Curves
were fit with Prism (Graphpad Software Inc.) according to a one site-specific
binding model.
To measure the competitive binding of wildtype and C387A NiV G to
ephrinB2-Fc, wildtype NiV G ectodomain was adsorbed to polystyrene ELISA
plates in 10 mM Tris pH 8.5 at 1 μg mL−1, then the surface was blocked with 1.5%
BSA in TBS. Mixtures with increasing concentration of competitor NiV G with
0.080 nM of ephrinB2-Fc were added, and ephrinB2-Fc binding to NiV G on the
plate was detected as above. Curves were fit with Prism (Graphpad Software Inc.)
to a one site-fit Ki model.
ELISA of conformation-specific antibody binding to NiV G. NiV G ectodomain
constructs were bound at 0.3 μg mL−1 via their membrane-proximal His6-tags to
Ni-NTA functionalized ELISA plates (Thermo Scientific) and titrated with
ephrinB2 constructs. mAb213 or mAb45 was bound at 1:6000 dilution followed by
incubation with anti-rabbit IgG-HRP antibody conjugate (AP187P, EMD
Millipore) at 1:10,000 dilution. The HRP signal was measured as described above.
mAb45 binding curves were fit with Prism (Graphpad Software Inc.) to a log
(agonist) vs. response-variable slope model with constraint of the bottom value to
the lowest absorbance value. mAb213 binding curves were fit with Prism
(Graphpad Software Inc.) to a log(inhibitor) vs. response-variable slope model with
no constraints.
Negative stain electron microscopy of NiV G mutants. All samples were diluted
in 25 mM Tris, pH 8.0, 200 mM NaCl, 100 mM imidazole to 0.01 mgmL−1 and
adsorbed on glow-discharged, carbon-coated copper grids. The samples were then
stained with 2% uranyl formate. Electron micrographs were obtained on a JEOL
1400 electron microscope at 120 keV and recorded on a GATAN Ultrascan 4000
CCD camera with no binning.
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EM 2D class averages of NiV G and NiV G-ephrinB2 complexes. 2.5 μL of 0.01
mgmL−1 apo-NiV G in TBS was loaded onto glow-discharged, carbon-coated
copper grids and stained with 2% uranyl acetate. His6-ephrinB2-167 was mixed
with NiV G at a 5:1 molar ratio at a NiV G protein concentration of 0.12 mgmL−1,
and ephrinB2-Fc was mixed with NiV G at a 10:1 molar ratio at a NiV G protein
concentration of 0.9 mgmL−1 prior to concentration with 10 K MWCO Corning
Spin-X concentrators to a 100 μL volume for loading onto a GL5/150 S200 column
with 3 mL bed volume. The complex peak of His6-ephrinB2-167-NiV G was
concentrated to 0.08 mgmL−1 for storage. The complex peak of ephrinB2-Fc-NiV
G was determined to be 0.09 mgmL−1 and stored without concentration. NiV G-
ephrinB2 complexes were diluted to 0.01 mgmL−1 for adsorption onto glow-
discharged carbon-coated copper grids. 140 electron micrographs were obtained on
a Tecnai TF20 electron microscope at 200 keV. Ctffind 447 was used to determine
the defocus value of each micrograph, ranging from 27,393 Å to 49,501 Å. 55,596
particles were picked without reference using DoGPicker48. Particle images were
windowed out in dimensions of 128 × 128 square pixels (pixel size of 4.28 Å),
followed by 2 rounds of 2-dimensional class averaging with Relion 1.449. 23,025
good particles were kept in the final round of classification. The total number of
particles picked for the His6-ephrinB2-167-NiV G complex was 47,666, yielding
40,015 good particles kept in the final round of classification. The location of the α-
helical stalk portions of NiV G were estimated by calculating the length of an α-
helix with the number of residues of the helical portion of the NiV G stalk (71–138,
corresponding to 102 Å), and placing an appropriately-scaled graphic on a
representative 2D class average of the NiV G tetramer based on the pixel size of 4.4
Å.
Hydrogen-deuterium exchange mass spectrometry. 12 μM NiV G ectodomain
was used to determine sequences of peptides obtained in HDX-MS after pepsin
digestion. 5 μM NiV G ectodomain was used as the apo-NiV G HDX-MS sample,
and 5 μM NiV G ectodomain mixed with 2x molar excess of His6-ephrinB2-167
was used as the ephrinB2-bound NiV G HDX-MS sample. All protein samples
were prepared in deuterated TBS, pD 7.5. Deuterated TBS was prepared by lyo-
philization of TBS and resuspension in D2O (Cambridge Isotopes). Triplicate
5 μL protein samples were mixed with 55 μL deuterated TBS at 25 °C, quenched
after 0.5, 1, 2, and 5 min with 125 mM sodium phosphate monobasic, pH 2.6, 250
mM TCEP for 1 min, and injected into a Waters G2-Si HDX-MS system (Waters,
Corp.) by a LEAP H/DX PAL autosampler. Protein samples were digested on-
column with immobilized pepsin (Pierce) at 0 °C, then separated by liquid chro-
matography on a Waters NanoACQUITY UPLC BEH C18 column with a 7–85%
acetonitrile gradient in 0.1% formic acid. Peptides were analyzed by electrospray
ionization mass spectrometry with ion mobility separation in a Synapt G2-Si
quadrupole time-of-flight mass spectrometer. Peptides were identified with Pro-
teinLynx Global Server (Waters Corp.). Mass spectra were assigned and H/D
exchange was determined with DynamX 3.0 (Waters Corp.). The back exchange
was < 30% and the data were corrected for this loss.
Data availability. All relevant data are available from the corresponding author
upon reasonable request.
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